Loading…
CIK 0002013410 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("fcpm-iii-services-b-v","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | $16.1M | 2.2%Prev: 7.1% | 3,468,430 SH | Decreased+16,100 SH |
| CRESCENT BIOPHARMA INC. | COM | $30.8M | 4.3% | 1,677,852 SH | New |
| DAMORA THERAPEUTICS INC | COM NEW | $63.2M | 8.8% | 2,441,000 SH | New |
| DYNE THERAPEUTICS INC | COM | $84.2M | 11.7%Prev: 13.8% | 4,644,386 SH | Increased-818,460 SH |
| ENGENE HOLDINGS INC | COM | $65.6M | 9.1%Prev: 10.4% | 9,632,561 SH | Increased |
| ENGENE HOLDINGS INC | W EXP 10/31/2028 | $7.3M | 1.0%Prev: 0.4% | 2,878,148 SH | Increased |
| MAPLIGHT THERAPEUTICS INC | COM | $65.6M | 9.1% | 3,226,400 SH | New |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $294.5M | 40.8%Prev: 54.1% | 9,198,900 SH | Increased-1,736,410 SH |
| REPLIMUNE GROUP INC | COM | $21.5M | 3.0%Prev: 9.2% | 2,808,368 SH | Decreased-1,101,328 SH |
| VOR BIOPHARMA INC | COM NEW | $73.5M | 10.2% | 4,117,354 SH | New |
| 13F-HR |
| 0001193125-26-350207 |
| $750.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950123-25-008060 | $369.2M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001193125-26-225423 | $722.2M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005517 | $413.7M | View |